The Visuo-attentional Mediator of Social Facilitation (VAMOS)

August 26, 2025 updated by: Hospices Civils de Lyon

Social psychology has long established that the mere presence of others influences the investigator's individual behavior and performance. "Social facilitation" refers to any improvement or deterioration of performance due to the presence of others. For more than a century, social psychology has acquired a solid knowledge of the principles governing this fundamental form of social influence.

But the underlying mechanism of social facilitation remains debated, as behavior alone cannot identify it with certainty. This major unresolved problem makes it particularly difficult to translate laboratory results on social facilitation into real applications in areas such as school or work, where others are ubiquitous. The purpose of this study will therefore be to identify the mediator of social facilitation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

43

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bron, France, 69500
        • Centre de Recherche en Neuroscience de Lyon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female
  • Aged 18 to 35 years old
  • Signed written informed consent
  • Insurance coverage

Exclusion Criteria:

  • Neurological or psychiatric or ophthalmological disorder
  • Non-stabilized medical condition
  • Ongoing treatment with drugs that affect the central nervous system

    • Uncorrected visual inadequacy
    • No fluency in French reading
    • Pregnant and / or breastfeeding woman, this exclusion criterion will be sought by questioning the subject
    • Subject commonly in care in a health or social facility for purposes other than that of research
    • Subject under guardianship
    • Subject deprived of liberty by a judicial or administrative decision
    • Incompatibility with the Magnetic Resonance Imaging (MRI) examination determined by answering the following questions:
  • Carrier of a neurological stimulator, cardiac (battery) or defibrillator
  • Carrier of a cardiac prosthesis (valve, stent ...) or vascular
  • Holder of intracranial clips or clamps (staples)
  • Carrier of a cerebrospinal fluid bypass
  • Presence of metal chips in the eyes
  • Metal prosthesis carrier (teeth, knees)
  • Pump carrier or infusion system
  • Presence of metal tattoo near the head
  • Presence of permanent makeup
  • Claustrophobia or respiratory disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Social Facilitation
Cognitive tasks during the 2 functional Magnetic Resonance Imaging (fMRI) observed or not by a subject's known peer.
During the functional Magnetic Resonance Imaging (fMRI) scans, the subject will perform cognitive tasks measuring eye movements and attention alternatively observed by a familiar peer (in an adjacent room) or not.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain activation
Time Frame: 50 minutes
Cerebral Blood Oxygenation Level-Dependent (BOLD) signals
50 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Behavioral performances
Time Frame: 50 minutes
pupillary diameter
50 minutes
Behavioral performances
Time Frame: 50 minutes
error rate
50 minutes
Behavioral performances
Time Frame: 50 minutes
reaction time
50 minutes
Behavioral performances
Time Frame: 50 minutes
oculomotor kinematic parameters: velocity of saccades.
50 minutes
Behavioral performances
Time Frame: 50 minutes
oculomotor kinematic parameters: duration of saccades.
50 minutes
Behavioral performances
Time Frame: 50 minutes
oculomotor kinematic parameters: precision of saccades.
50 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Denis PELISSON, Centre de Recherche en Neuroscience de Lyon

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 16, 2021

Primary Completion (Actual)

May 18, 2022

Study Completion (Actual)

May 18, 2022

Study Registration Dates

First Submitted

April 12, 2019

First Submitted That Met QC Criteria

April 25, 2019

First Posted (Actual)

April 26, 2019

Study Record Updates

Last Update Posted (Estimated)

September 3, 2025

Last Update Submitted That Met QC Criteria

August 26, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 69HCL19_0268
  • 2019-A01027-50 (Other Identifier: ID-RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Facilitation

Clinical Trials on Social Facilitation

Subscribe